BioNJ is pleased that the Health Care Reform Act was passed. Our position prior to its passing appears below. BioNJ is in agreement with the general position advanced by BIO… Read the full article

BioNJ is pleased that a regulatory pathway for biosimilars was included in the Health Care Reform Act. Our position prior to its inclusion and passage appears below. From its inception,… Read the full article